Public-private partnerships for e-government in developing countries: An early stage assessment framework.

08:00 EDT 23rd October 2018 | BioPortfolio

Summary of "Public-private partnerships for e-government in developing countries: An early stage assessment framework."

Although public-private partnerships (PPP) and electronic government (e-government) have proven to be fruitful mechanisms for economic development and emerging economies seem to recognize their importance, consistent methods for analyzing the early planning stages of e-government portfolios are lacking. The present work utilized a comprehensive literature review to understand the evaluation criteria for PPP projects throughout the early-stage planning process. A qualitative meta-synthesis was employed to identify critical factors for PPP and e-government, with a particular focus on developing countries, PPP, and e-government criteria. Our research presents a framework named "PPP4e-Gov" (public-private partnerships for e-government). The framework compares risk and value factors of e-government PPP projects and adopts a weighted scoring model that estimates the risks that should be considered in a project and how much value a given e-government initiative may generate if the PPP option is chosen. As an illustration of how the framework may be used, the paper interviewed ten practitioners in Costa Rica who tried out PPP4e-Gov and showcased how to plan their e-government initiatives.


Journal Details

This article was published in the following journal.

Name: Evaluation and program planning
ISSN: 1873-7870
Pages: 205-218


DeepDyve research library

PubMed Articles [20048 Associated PubMed Articles listed on BioPortfolio]

Civil society participation in global public private partnerships for health.

The growth of global public-private partnerships for health has opened up new spaces for civil society participation in global health governance. Such participation is often justified by the claim tha...

Addressing Maternal Mortality And Morbidity In California Through Public-Private Partnerships.

In 2006, noting a rise in maternal deaths and complications, the California Department of Public Health launched efforts to investigate maternal deaths. In that year, the California Maternal Quality C...

Clinical trials in developing countries - ethical considerations.

When designing clinical trial or considering decision to take part in particular clinical trial as investigators, even before submission to responsible Central Ethic Committee, we always make certain ...

Hong Kong's role in global health: Public opinion of official development assistance.

Governments in high income countries allocate funding for Official Development Assistance (ODA), and population-based surveys tend to show support for the concept of affluent nations assisting the dev...

The food environment of Brazilian public and private schools.

This study's aim was to characterize the food environment of Brazilian public and private schools. This was a national school-based cross-sectional study with 1,247 schools - among which 81.09% were p...

Clinical Trials [10463 Associated Clinical Trials listed on BioPortfolio]

Postpregnancy Family Planning Choices in Public and Private Sectors in Kenya and Indonesia

The primary goal of PPFP Choices is to generate actionable evidence that can be used to increase programmatic activities to address post-pregnancy family planning in the public and private...

Improving the Quality of Private Sector Health Care in West Bengal

The rural healthcare market in much of the developing world is composed largely of informal private providers. These private providers often have little to no certifiable medical training....

Vitamin A Total Body Stores of Senegalese Children in Relation to Their Infectious Status

Despite economic growth in developing countries, Sub-Saharan Africa still faces food insecurity malnutrition and infections. Micronutrient deficiency and infectious diseases still remain a...

Effects of Psychosocial Stimulation and Cash on Children's Development and Behaviour

Burden: In developing countries, an estimated 219 million children do not reach their maximum potentiality because of poverty and associated risk factors. More than half of the Bangladeshi...

Cultural Congruence in International Genetics Research

This study will explore how cultural differences influence genetics research in developing countries. Human genetics research is becoming more common in developing countries. However, when...

Medical and Biotech [MESH] Definitions

An organizational enterprise between a public sector agency, federal, state or local, and a private sector entity. Skills and assets of each sector are shared to deliver a service or facility for the benefit or use of the general public.

Spread and adoption of inventions and techniques from one geographic area to another, from one discipline to another, or from one sector of the economy to another. For example, improvements in medical equipment may be transferred from industrial countries to developing countries, advances arising from aerospace engineering may be applied to equipment for persons with disabilities, and innovations in science arising from government research are made available to private enterprise.

Diseases that are underfunded and have low name recognition but are major burdens in less developed countries. The World Health Organization has designated six tropical infectious diseases as being neglected in industrialized countries that are endemic in many developing countries (HELMINTHIASIS; LEPROSY; LYMPHATIC FILARIASIS; ONCHOCERCIASIS; SCHISTOSOMIASIS; and TRACHOMA).

Methods to determine in patients the nature of a disease or disorder at its early stage of progression. Generally, early diagnosis improves PROGNOSIS and TREATMENT OUTCOME.

Spaces and needed equipment provided for a specific, non-medical function or service used by the public or specific group of persons.

Quick Search


DeepDyve research library

Relevant Topic

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.

Searches Linking to this Article